Patent details

Basic Information

Publication number:

EP3514172

WO Application Number:

Type:

European Patent Granted for NL

Status:

Patent in Force

Publication Title:

Title When Made Available For Viewing:

Reason Lapsed:

Application number:

EP19151238.3

WO Publication Number:

EPO Publication Language:

English

SPC Number:

First Applicant Residence Country:

Germany (DE)

Publications:

Dates

Filing date:

30/03/2015

Grant date:

11/03/2020

EP Publication Date:

24/07/2019

WO Publication Date:

Claims Translations Received Date:

Claims Translation B1 Received Date:

26/03/2020

Claims Translation B2 Received Date:

Claims Translation B3 Received Date:

Lapsed By Non Payment Annual Fee Date:

Renunciation Date:

NullificationDate:

Published:

Due To Cession Date:

Registration date:

11/03/2020

EP B1 Publication Date:

11/03/2020

EP B2 Publication Date:

EP B3 Publication Date:

Description Translation B1 Received Date:

Description Translation B2 Received Date:

Description Translation B3 Received Date:

Expiration date:

29/03/2035

Lapsed By Expiration Date:

Patent Validated Date:

10/04/2020

Revocation Date:

Invalidity Date:

Response To Novelty Search Report Received:

Patent Granting Request:

Lapsed date:

Applicant/holder

From:

18/01/2024

 

 

 

Name:

BioNTech Cell & Gene Therapies GmbH

Address:

An der Goldgrube 12, 55131 Mainz, Germany (DE)

From:

18/01/2024

 

 

 

Name:

TRON - Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg- Universität Mainz gemeinnützige GmbH

Address:

Freiligrathstrasse 12, 55131 Mainz, Germany (DE)

From:

18/01/2024

 

 

 

Name:

Astellas Pharma Inc.

Address:

5-1, Nihonbashi-Honcho 2-Chome Chuo-ku, 103-8411, Tokyo, Japan (JP)

Historical Applicant/holder

From:

11/03/2020

To:

18/01/2024

 

Name:

BioNTech Cell & Gene Therapies GmbH

Address:

An der Goldgrube 12, 55131 Mainz, Germany (DE)

From:

11/03/2020

To:

18/01/2024

 

Name:

TRON - Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg- Universität Mainz gemeinnützige GmbH

Address:

Freiligrathstrasse 12, 55131 Mainz, Germany (DE)

From:

11/03/2020

To:

18/01/2024

 

Name:

Ganymed Pharmaceuticals GmbH

Address:

An der Goldgrube 12, 55131 Mainz, Germany (DE)

Agent

Name:

dr. A. Krebs

From:

09/04/2020

Address:

HGF B.V. Benoordenhoutseweg 46, 2596 BC, Den Haag, Netherlands (NL)

To:

Inventor

1

Name:

SAHIN, Ugur

Address:

55116 Mainz, Germany (DE)

2

Name:

TÜRECI, Özlem

Address:

55116 Mainz, Germany (DE)

3

Name:

OEHM, Petra

Address:

55129 Mainz, Germany (DE)

4

Name:

OMOKOKO, Tana

Address:

55116 Mainz, Germany (DE)

5

Name:

HOFF, Holger

Address:

10115 Berlin, Germany (DE)

6

Name:

VOSS, Ralf-Holger

Address:

55218 Ingelheim, Germany (DE)

7

Name:

BREITKREUZ, Andrea

Address:

67551 Worms, Germany (DE)

8

Name:

HOBOHM, Kathleen

Address:

65779 Kelkheim i. Ts., Germany (DE)

9

Name:

MROZ, Karolina Anna

Address:

55131 Mainz, Germany (DE)

Priority

1

Priority Patent Number:

PCT/EP2014/072864

Priority Date:

24/10/2014

Priority Country:

World Intellectual Property Office (WIPO) (WO)

2

Priority Patent Number:

PCT/EP2014/000868

Priority Date:

01/04/2014

Priority Country:

World Intellectual Property Office (WIPO) (WO)

Classification

IPC or IDT classification:

A61P 35/00; C07K 14/47; C07K 14/725; A61K 35/26;

Publication

Bulletin

1

Bulletin Heading:

CO

Journal edition number:

04/24

Publication date:

24/01/2024

Description:

Changes in the Netherlands Patent Register

2

Bulletin Heading:

EP3

Journal edition number:

16/20

Publication date:

15/04/2020

Description:

European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995

3

Bulletin Heading:

EP2

Journal edition number:

11/20

Publication date:

11/03/2020

Description:

European patents granted for the Netherlands

European Patent Bulletin

1

Issue number:

202015

Publication date:

08/04/2020

Description:

Application number/publication number of the divisional application (Art. 76) changed

2

Issue number:

202013

Publication date:

25/03/2020

Description:

Inventor(s) changed

3

Issue number:

202011

Publication date:

11/03/2020

Description:

Grant (B1)

Deed

Change of owner(s)

Change Kind/ Decision Type:

Assignment

Deed Number:

RC202400121A

Date Registered:

18/01/2024

License Effective Date:

License Expiration Date:

Scope of License:

Deed Filer:

dr. A. Krebs

Journal Edition Number:

Text:

Deed Status:

Country Code:

Updated License Number:

Terminated License Number:

Added Owner(s)

1

Name:

TRON - Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg- Universität Mainz gemeinnützige GmbH

Address:

Freiligrathstrasse 12, 55131 Mainz, Germany (DE)

2

Name:

BioNTech Cell & Gene Therapies GmbH

Address:

An der Goldgrube 12, 55131 Mainz, Germany (DE)

3

Name:

Astellas Pharma Inc.

Address:

5-1, Nihonbashi-Honcho 2-Chome Chuo-ku, 103-8411, Tokyo, Japan (JP)

Changed Pledgee

Name:

Address:

Removed Usufructuary

Name:

Address:

Added Usufructuary

Name:

Address:

Changed Usufructuary

Name:

Address:

Annual Fee

Annual Fee(s) Due Date:

31/03/2026

Annual Fee Number:

12

Annual Fee Amount:

600 Euro

Last Annual Payment Date:

24/03/2025

Last Annual Fee Paid Number:

11

Last Annual Fee Paid Amount:

500 Euro

Payer:

PAVIS GmbH

	Filing date	Document type	Document Description	Number of pages	File Type
	09/04/2020	Outgoing Correspondence	Letter no formal defects	1	PDF	/3/0/1/8/2/0800528103/docs/ep19151238.3_1_337863l271.pdf
	26/03/2020	Claims	First filed claims	4	PDF	/3/0/1/8/2/0800528103/docs/ep19151238.3_0_claims20200326124544985.pdf